Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.11

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (20795)	8/10/2006 3:02:31 PM
From: dr.praveen	Read Replies (2) of 52153

Does anyone think Exelixis is undervalued at these levels after listening to their latest C/C? I agree that we are in for a long haul in regards to pipeline maturity and the next major catalyst could be a few more partnerships and GSK opting for Exelixis cpds. Not to forget the possibility of a dilution if the above doesn't happen and the burn get's worse. Am i missing something:-)? Thanks...Praveen

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next